Company Financials

AbbVie Financials

United States dollar

business AbbVie Company Profile

Main Stock Listing

NYSE: ABBV

Market Capitalization $405.28 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 171.80
Forward PE 16.03
Price to Sales TTM $6.77
Price to Book MRQ $-155.93
Enterprise to Revenue 7.83
Enterprise to EBITDA 15.82

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 4.00%
Operating Margin 35.50%
Return on Assets TTM 9.59%
Return on Equity TTM 137.96%

Income Statement

Revenue TTM $59,643,998,208
Revenue per Share TTM $33.72
Quarterly Revenue Growth 9.10%
Gross Profit TTM $42,622,001,152
EBITDA $18,186,000,000
Net Income to Common TTM $2,348,000,000
Diluted EPS TTM $1.33
Quarterly Earnings Growth YoY -88.10%

Balance Sheet

Total Cash MRQ $5,671,000,064
Total Cash per Share MRQ $3.21
Total Debt MRQ $
Total Debt to Equity MRQ -26.49
Current Ratio MRQ 0.73
Book Value per Share MRQ $-1.50

Cash Flow

Operating Cash Flow TTM $20,860,000,256
Levered Free Cash Flow TTM $20,799,000,576

ABBV Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,767,349,878
Float Shares 1,763,938,232
Avg 10 Volume 5,009,950
Avg 30 Volume None
Shares Short 18,075,534
Short Ratio 3.21
Short % of Shares 1.02%
% Held by Insiders 0.10%
% Held by Institutions 75.21%

Stock Price Summary

Beta 0.35
Fifty Two Week Low $164.39
Fifty Two Week High $244.81
Fifty Two Week Change 20.97%
Day 50 MA $226.77
Day 200 MA $205.99

Dividends and Splits

Forward Annual Dividend Rate $6.56
Forward Annual Dividend Yield 2.86%
Trailing Annual Dividend Rate $6.56
Trailing Annual Dividend Yield 2.86%
Payout Ratio 490.15%
Dividend Date 2026-02-17
Ex Dividend Date 2026-01-16
Last Split Factor
Last Split Date